我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
0
0 进行中
药物批准
68
批准总数
监管机构
1
监管机构数
成立时间
1984
暂无试验阶段数据
暂无试验数据
FDA
Food and Drug Administration
- Otsuka ICU Medical LLC issued a voluntary nationwide, user-level recall of one lot of 0.9% Sodium Chloride Injection, USP, 100 mL single pack after a product mix-up. - A customer complaint reported a 10 mEq highly concentrated potassium chloride bag inside an overwrap labeled as 0.9% sodium chloride injection. - The company states inadvertent injection of highly concentrated potassium chloride carries a reasonable probability of adverse events and potentially fatal outcomes. - No adverse events related to the recall have been reported to Otsuka ICU Medical LLC, and the FDA has been notified of the action.